Medical Marijuana May Aid in Epilepsy Treatments

Sufferers of epilepsy may find respite from their ailments in the form of a new drug: liquid medical marijuana. The possibility of such a treatment has emerged from the study supported by GW Pharmaceuticals, and published by theAmerican Academy of Neurology. According to the research, the cannabidiol compound found in marijuana, a compound devoid of the capacity to induce any psychoactive high, can help in deterring the physical reactions of epilepsy. Participants in the study suffer from severe forms of epilepsy, some having Dravet syndrome, while others are stricken with Lennox-Gastaut syndrome, both of which can significantly impair intellectual and physical development. Igor Cornelsen, ( has read that participants across the board, regardless of the particular type of epilepsy, experienced a drop in the frequency of seizures suffered after taking the cannabidiol medication. Admittedly, some participants experienced negative side effects. Combined with a lack of any meaningful control group in the study, the completion of further experimentation is necessary before heralding this new treatment as a permanent means of treating severe cases of epilepsy.

That being said, one would hope that should this information and treatment be solidified as an appropriate and successful method of dealing with epilepsy, necessary government agencies or officials would step in to allow said treatment to reach those most in need of it. If such involvement entails sanctioning the use of medical marijuana in a higher number of our states, then so be it.

Pediatricians Are Against Jail Time For Weed Smoking Teenagers

The American Academy of Pediatrics Recently Revised Its Policy On Medical Marijuana

Science hasn’t quite caught up with the looming medical marijuana frenzy. Twenty-three states now say the use of marijuana for medical purposes is legal, but there’s hasn’t been much research done on pot’s effects on teenage brains.

The American Academy of Pediatrics has revised its policy on medical marijuana. The revised policy is pediatricians should not prescribe pot to children until there is more research is done. People at Slow Ventures have found that the Academy did say that cases where patients are suffering from chronic, and seriously debilitating conditions are exempt from the new policy. The other recommendation is weed should be decriminalized, but they are still against legalization.

The policy is somewhat confusing to some people but according to Dr. Seth Ammerman, a pediatrician at Stanford University, the policy speaks for itself. He says arresting doobie smoking teens doesn’t do anyone any good. Thousands of teens have been arrested for marijuana possession, and that hasn’t slowed its use in that age group.

Dr. Ammerman stance and the stance of pediatricians around the country is teen pot smoking is a public health issues, not a criminal justice issue and it should be treated that way.